Extracellular domain ERBB2 (ERBB2 ECD+) mutations in urothelial bladder cancer (UBC).

被引:0
|
作者
Basin, Michael
Jacob, Joseph M.
Bratslavsky, Gennady
Grivas, Petros
Spiess, Philippe E.
Li, Roger
Necchi, Andrea
Pavlick, Dean C.
Huang, Richard S. P.
Lin, Douglas I.
Danziger, Natalie
Sokol, Ethan
Sivakumar, Smruthy
Ross, Jeffrey S.
机构
[1] SUNY Upstate Med Univ, Syracuse, NY USA
[2] Univ Washington, Div Oncol, Dept Med,Seattle Canc Care Alliance, Fred Hutchinson Canc Res Ctr, Seattle, WA USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] Univ Vita Salute San Raffaele, Milan, Italy
[5] IRCCS San Raffaele Hosp & Sci Inst, Dept Med Oncol, Milan, Italy
[6] Fdn Med Inc, Cambridge, MA USA
[7] Fdn Med Inc, Morrisville, NC USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
566
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Micropapillary histology (MPUC) and extra-cellular domain ERBB2 (ERBB2 ECD+) mutations in urothelial bladder cancer (UBC)
    Sood, A.
    Jacob, J. M.
    Bratslavsky, G.
    Grivas, P.
    Spiess, P.
    Li, R.
    Necchi, A.
    Posada, J.
    Yakirevich, E.
    Cheng, L.
    Pavlick, D. C.
    Huang, R.
    Lin, D. I.
    Danziger, N. A.
    Sokol, E. S.
    Sivakumar, S.
    Ross, J. S.
    Kamat, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1219 - S1220
  • [2] Oncogenic extracellular domain mutations of ERBB2 in cancer
    Greulich, Heidi
    Kaplan, Bethany
    Mertins, Philipp
    Chen, Tzu-Hsiu
    Tanaka, Kumiko
    Yun, Cai-Hong
    Imielinski, Marcin
    Banerji, Shanatanu
    Lawrence, Michael S.
    Walker, Sarah
    Winckler, Wendy
    Getz, Gad
    Frank, David
    Eck, Michael
    Jaffe, Jacob D.
    Carr, Steven A.
    Wong, Kwok-Kin
    Meyerson, Matthew
    CANCER RESEARCH, 2012, 72
  • [3] TARGETING ERBB2 MUTATIONS IN UROTHELIAL CARCINOMA
    Audenet, Francois
    Isharwal, Sumit
    Arcila, Maria
    Funt, Samuel
    Rosenberg, Jonathan
    Bajorin, Dean
    Cha, Eugene
    Donahue, Timothy
    Donat, Machele
    Herr, Harry
    Dalbagni, Guido
    Bochner, Bernard
    Berger, Michael
    Al-Ahmadie, Hikmat
    Solit, David
    Iyer, Gopa
    JOURNAL OF UROLOGY, 2017, 197 (04): : E643 - E644
  • [4] Targeting ERBB2 mutations in urothelial carcinoma.
    Audenet, Francois
    Isharwal, Sumit
    Arcila, Maria E.
    Funt, Samuel
    Rosenberg, Jonathan E.
    Bajorin, Dean F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [5] ERBB2 signaling and inhibition in bladder cancer
    Caparas-Spaugy, Constance
    Stubben, Chris
    Boucher, Ken
    Feng, Bingjian
    Atkinson, Aaron
    Nix, David
    Cairns, Bradley
    Gupta, Sumati
    CANCER RESEARCH, 2024, 84 (06)
  • [6] Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib
    de Martino, Michela
    Zhuang, Dazhong
    Klatte, Tobias
    Rieken, Malte
    Roupret, Morgan
    Xylinas, Evanguelos
    Clozel, Thomas
    Krzywinski, Martin
    Elemento, Olivier
    Shariat, Shahrokh F.
    CANCER BIOLOGY & THERAPY, 2014, 15 (09) : 1239 - 1247
  • [7] Molecular architecture of the ErbB2 extracellular domain homodimer
    Hu, Shi
    Sun, Yuna
    Meng, Yanchun
    Wang, Xiaoze
    Yang, Weili
    Fu, Wenyan
    Guo, Huaizu
    Qian, Weizhu
    Hou, Sheng
    Li, Bohua
    Rao, Zihe
    Lou, Zhiyong
    Guo, Yajun
    ONCOTARGET, 2015, 6 (03) : 1695 - 1706
  • [8] ERBB2 mutations and association with molecular phenotype in urothelial carcinoma
    Machaalani, Marc
    El Zarif, Talal
    Stockhammer, Paul
    Semaan, Karl
    Eid, Marc
    Chehade, Razane El Hajj
    Nawfal, Rashad
    Yekeduz, Emre
    Nassar, Amin
    Lee, Gwo-Shu Mary
    Baca, Sylvan C.
    Choueiri, Toni K.
    Grant, Michael J.
    Bellmunt, Joaquim
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2
    Posada, Jessica M.
    Yakirevich, Evgeny
    Kamat, Ashish M.
    Sood, Akshay
    Jacob, Joseph M.
    Bratslavsky, Gennady
    Grivas, Petros
    Spiess, Philippe E.
    Li, Roger
    Necchi, Andrea
    Mega, Anthony E.
    Golijanin, Dragan J.
    Pavlick, Dean
    Huang, Richard S. P.
    Lin, Douglas
    Danziger, Natalie
    Sokol, Ethan S.
    Sivakumar, Smruthy
    Ross, Jeffrey S.
    Cheng, Liang
    MODERN PATHOLOGY, 2024, 37 (03)
  • [10] Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1
    Li, Guangyuan
    Wang, Xiaoqi
    Hibshoosh, Hanina
    Jin, Cheng
    Halmos, Balazs
    PLOS ONE, 2014, 9 (09):